What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate cancer?
evidence, the committee recommended not offering mapping transperineal template biopsy as an initial biopsy, because the technique is...
Search results
7 results for template
-
-
Paige Prostate for prostate cancer (MIB280)
NICE has developed a medtech innovation briefing (MIB) on Paige Prostate for prostate cancer
-
trublood-prostate for triaging and diagnosing people with prostate cancer symptoms (MIB268)
NICE has developed a medtech innovation briefing (MIB) on trublood-prostate for triaging and diagnosing people with prostate cancer symptoms
-
The percentage of patients with cancer, diagnosed within the preceding 24 months, who have a patient Cancer Care Review using a structured template within 12 months of diagnosis
preceding 24 months, who have a patient Cancer Care Review using a structured template within 12 months of diagnosis Subject(s): Cancer
-
Artificial intelligence for analysing CT brain scans (MIB207)
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence for analysing CT brain scans
-
What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate cancer?
evidence, the committee recommended not offering mapping transperineal template biopsy as an initial biopsy, because the technique is...
-
What is the natural history of people with a Likert score on MRI of less than 3 without biopsy at long-term follow‑up?
evidence, the committee recommended not offering mapping transperineal template biopsy as an initial biopsy, because the technique is...